News Medical on MSN
New oral contrast agent improves bowel disease detection on CT scans
In a new pilot feasibility study, researchers from Mayo Clinic, the University of Washington School of Medicine, the ...
Centargo compatible with Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), Omnipaque™ (iohexol) and now, Visipaque™ (iodixanol) Follows recent FDA clearance to expand the use of ...
Nanomedicine. 2015;10(2):321-341. Delivery: "Go where we want." The contrast agent must be able to be delivered in vivo and transported to the site of interest. Nontoxic: "Do no harm along the way." ...
Contrast media used for medical imaging may be contributing to environmental pollution as researchers measure and consider the impact.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results